Full threadforkexec·No mention of Camostat plus E-64d that is already known to blockade TMPRSS2 and ACE2. E-64d needs full clinical trials while Camostat needs enhanced Phase IV trials since it's already Rx in Japan.https://www.cell.com/cell/fulltext/S0092-8674(20)30229-4View on HN